{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:28Z","timestamp":1756902148057,"version":"3.44.0"},"reference-count":20,"publisher":"The Pediatric Pharmacy Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"abstract":"<jats:p>\n          <jats:bold>OBJECTIVES:<\/jats:bold> The objective of this study was to identify neonatal and maternal characteristics that may be associated with elevated neonatal gentamicin trough concentrations despite application of a previously published gentamicin dosage strategy.<\/jats:p>\n        <jats:p>\n          <jats:bold>METHODS:<\/jats:bold> Retrospective cohort study of all neonates admitted to University of Vermont Medical Center (562-bed academic teaching hospital, Burlington, VT) receiving gentamicin between June 1, 2009, and August 31, 2013. A total of 205 neonates were included, with 41 cases and 164 controls.<\/jats:p>\n        <jats:p>\n          <jats:bold>RESULTS:<\/jats:bold> Postmenstrual age (PMA, gestational age plus chronological age) and small-for\u2013gestational age (SGA) status were independently associated with elevated neonatal gentamicin trough concentrations. No maternal risk factor evaluated remained significantly associated in the multivariate analysis.<\/jats:p>\n        <jats:p>\n          <jats:bold>CONCLUSIONS:<\/jats:bold> The probability of an elevated gentamicin trough concentration increases with lower PMA and is further accentuated in neonates with SGA status. In contrast, the presence of maternal risk factors did not increase the likelihood of elevated gentamicin trough concentrations. Neonates with lower PMA and SGA status may require an individualized dosage and monitoring strategy.<\/jats:p>","DOI":"10.5863\/1551-6776-21.2.133","type":"journal-article","created":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T19:25:04Z","timestamp":1463426704000},"page":"133-139","source":"Crossref","is-referenced-by-count":0,"title":["Identification of Risk Factors for Elevated Neonatal Gentamicin Trough Concentrations"],"prefix":"10.5863","volume":"21","author":[{"given":"Jeffrey","family":"Gonzalez","sequence":"first","affiliation":[{"name":"Pharmacy Services, Vermont Children's Hospital, University of Vermont Medical Center, Burlington, Vermont"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Ahern","sequence":"additional","affiliation":[{"name":"Pharmacy Services, Vermont Children's Hospital, University of Vermont Medical Center, Burlington, Vermont"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Noyes","sequence":"additional","affiliation":[{"name":"Pharmacy Services, Vermont Children's Hospital, University of Vermont Medical Center, Burlington, Vermont"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Corriveau","sequence":"additional","affiliation":[{"name":"Pharmacy Services, Vermont Children's Hospital, University of Vermont Medical Center, Burlington, Vermont"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Mercier","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care, Vermont Children's Hospital, University of Vermont Medical Center, Burlington, Vermont"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"2","key":"i1551-6776-21-2-133-b1","series-title":"Pediatrics","first-page":"e18","article-title":"Decline in sepsis-associated neonatal and infant deaths in the United States, 1979 through 1994","volume":"102","year":"1998","unstructured":"Stoll\n              BJ, \n            \n              Holman\n              RC, \n            \n              Schuchat\n              A.\n            \n          \n          Decline in sepsis-associated neonatal and infant deaths in the United States, 1979 through 1994. Pediatrics. 1998;102(2):e18."},{"issue":"2","key":"i1551-6776-21-2-133-b2","series-title":"Clin Pharmacokinet","first-page":"71","article-title":"Therapeutic drug monitoring of aminoglycosides in neonates","volume":"48","year":"2009","unstructured":"Touw\n              DJ, \n            \n              Westerman\n              E, \n            \n              Sprij\n              AJ.\n            \n          \n          Therapeutic drug monitoring of aminoglycosides in neonates. Clin Pharmacokinet. 2009;48(2):71\u201388."},{"issue":"6","key":"i1551-6776-21-2-133-b3","series-title":"J Paediatr Child Health","first-page":"577","article-title":"Gentamicin dosage intervals in neonates: longer dosage interval\u2014less toxicity","volume":"34","year":"1998","unstructured":"Davies\n              MW, \n            \n              Cartwright\n              DW.\n            \n          \n          Gentamicin dosage intervals in neonates: longer dosage interval\u2014less toxicity. J Paediatr Child Health. 1998;34(6):577\u2013580."},{"issue":"suppl","key":"i1551-6776-21-2-133-b4","series-title":"J Infect Dis","first-page":"S98","article-title":"Pharmacology of gentamicin in man","volume":"124","year":"1971","unstructured":"Riff\n              LJ, \n            \n              Jackson\n              GG.\n            \n          \n          Pharmacology of gentamicin in man. J Infect Dis. 1971;124(suppl):S98\u2013S105."},{"issue":"2","key":"i1551-6776-21-2-133-b5","series-title":"J Health Popul Nutr","first-page":"163","article-title":"Extended-interval dosing of gentamicin for treatment of neonatal sepsis in developed and developing countries","volume":"26","year":"2008","unstructured":"Darmstadt\n              GL, \n            \n              Miller-Bell\n              M, \n            \n              Batra\n              M, \n          \n          et al. Extended-interval dosing of gentamicin for treatment of neonatal sepsis in developed and developing countries. J Health Popul Nutr. 2008;26(2):163\u2013182."},{"issue":"10","key":"i1551-6776-21-2-133-b6","series-title":"Pediatr Nephrol","first-page":"1389","article-title":"Acute effects of gentamicin on glomerular and tubular functions in preterm neonates","volume":"21","year":"2006","unstructured":"Tugay\n              S, \n            \n              Bircan\n              Z, \n            \n              Ca\u011flayan\n              C, \n          \n          et al. Acute effects of gentamicin on glomerular and tubular functions in preterm neonates. Pediatr Nephrol. 2006;21(10):1389\u20131392."},{"issue":"6 Pt 1","key":"i1551-6776-21-2-133-b7","series-title":"Pediatrics","first-page":"1228","article-title":"Once-daily gentamicin dosing in newborn infants","volume":"103","year":"1999","unstructured":"Lundergan\n              FS, \n            \n              Glasscock\n              GF, \n            \n              Kim\n              EH, \n          \n          et al. Once-daily gentamicin dosing in newborn infants. Pediatrics. 1999;103(6 Pt 1):1228\u20131234."},{"issue":"3","key":"i1551-6776-21-2-133-b8","series-title":"Expert Rev Anti Infect Ther","first-page":"319","article-title":"Aminoglycoside toxicity in neonates: something to worry about?","volume":"12","year":"2014","unstructured":"Kent\n              A, \n            \n              Turner\n              MA, \n            \n              Sharland\n              M, \n          \n          et al. Aminoglycoside toxicity in neonates: something to worry about?Expert Rev Anti Infect Ther. 2014;12(3):319\u2013331."},{"key":"i1551-6776-21-2-133-b9","series-title":"J Pediatr Pharmacol Ther","first-page":"192","article-title":"Development of a gentamicin and tobramycin dosing strategy in the neonatal intensive care unit","volume":"9","year":"2004","unstructured":"Niemic\n              KM, \n            \n              Corriveau\n              MP, \n            \n              Ahern\n              JW.\n            \n          \n          Development of a gentamicin and tobramycin dosing strategy in the neonatal intensive care unit. J Pediatr Pharmacol Ther. 2004;9:192\u2013197."},{"issue":"3","key":"i1551-6776-21-2-133-b10","series-title":"Clin Pharmacol Ther","first-page":"362","article-title":"Kinetic model for gentamicin dosing with the use of individual patient parameters","volume":"21","year":"1977","unstructured":"Sawchuk\n              RJ, \n            \n              Zaske\n              DE, \n            \n              Cipolle\n              RJ, \n          \n          et al. Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin Pharmacol Ther. 1977;21(3):362\u2013369."},{"key":"i1551-6776-21-2-133-b11","series-title":"J Matern Fetal Med","first-page":"124","article-title":"The case for \u201chybrid fetal growth curves\u201d: a population based estimation of normal fetal size across gestational age","volume":"5","year":"1996","unstructured":"Bernstein\n              IM, \n            \n              Mohs\n              G, \n            \n              Rucquoi\n              M, \n          \n          et al. The case for \u201chybrid fetal growth curves\u201d: a population based estimation of normal fetal size across gestational age. J Matern Fetal Med. 1996;5:124\u2013127."},{"key":"i1551-6776-21-2-133-b12","series-title":"BMC Pediatr","first-page":"59","article-title":"A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants","volume":"13","year":"2013","unstructured":"Fenton\n              TR, \n            \n              Kim\n              JH.\n            \n          \n          A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013;13:59."},{"issue":"7","key":"i1551-6776-21-2-133-b13","series-title":"Neonatal Netw","first-page":"19","article-title":"A review of gentamicin use in neonates","volume":"12","year":"1993","unstructured":"Fisk\n              K.\n            \n          \n          A review of gentamicin use in neonates. Neonatal Netw. 1993;12(7):19\u201323."},{"issue":"1","key":"i1551-6776-21-2-133-b14","series-title":"J Antimicrob Chemother","first-page":"13","article-title":"Newborns and gentamicin\u2014how much and how often?","volume":"49","year":"2002","unstructured":"Chattopadhyay\n              B.\n            \n          \n          Newborns and gentamicin\u2014how much and how often?\n          J Antimicrob Chemother. 2002;49(1):13\u201316."},{"issue":"4","key":"i1551-6776-21-2-133-b15","series-title":"J Matern Fetal Neonatal Med","first-page":"388","article-title":"Renal function is impaired in small for gestational age premature infants","volume":"26","year":"2013","unstructured":"Aly\n              H, \n            \n              Davies\n              J, \n            \n              El-Dib\n              M, \n          \n          et al. Renal function is impaired in small for gestational age premature infants. J Matern Fetal Neonatal Med. 2013;26(4):388\u2013391."},{"key":"i1551-6776-21-2-133-b16","series-title":"J Clin Pharmacol","first-page":"39","article-title":"Impact of small-for-gestational (SGA) status on gentamicin pharmacokinetics in neonates","volume":"54","year":"2014","unstructured":"Lulic-Botica\n              M, \n            \n              Sheer\n              T, \n            \n              Edwards\n              D, \n          \n          et al. Impact of small-for-gestational (SGA) status on gentamicin pharmacokinetics in neonates. J Clin Pharmacol. 2014;54:39\u201345."},{"issue":"1","key":"i1551-6776-21-2-133-b17","series-title":"Indian J Pharmacol","first-page":"36","article-title":"Pharmacokinetic approach for optimizing gentamicin use in neonates during the first week of life","volume":"44","year":"2012","unstructured":"Ali\n              AS, \n            \n              Farouq\n              F, \n            \n              Al-Faify\n              K.\n            \n          \n          Pharmacokinetic approach for optimizing gentamicin use in neonates during the first week of life. Indian J Pharmacol. 2012;44(1):36\u201340."},{"key":"i1551-6776-21-2-133-b18","series-title":"J Urol","first-page":"714","article-title":"Developmental renal physiology of the low birth weight pre-term newborn","volume":"156","year":"1996","unstructured":"Chevalier\n              RL.\n            \n          \n          Developmental renal physiology of the low birth weight pre-term newborn. J Urol. 1996;156:714\u2013719."},{"key":"i1551-6776-21-2-133-b19","series-title":"Am J Health-Syst Pharm","first-page":"1319","article-title":"Development of criteria for gentamicin monitoring in a neonatal intensive care unit","volume":"69","year":"2012","unstructured":"Stach\n              LM, \n            \n              Pallotoo\n              E, \n            \n              Sandritter\n              T.\n            \n          \n          Development of criteria for gentamicin monitoring in a neonatal intensive care unit. Am J Health-Syst Pharm. 2012;69:1319\u20131325."},{"issue":"3","key":"i1551-6776-21-2-133-b20","series-title":"Am J Perinatol","first-page":"262","article-title":"An evaluation of gentamicin dosing according to renal function in neonates with suspected sepsis","volume":"4","year":"1987","unstructured":"Reimche\n              LD, \n            \n              Rooney\n              ME, \n            \n              Hindmarsh\n              KW, \n          \n          et al. An evaluation of gentamicin dosing according to renal function in neonates with suspected sepsis. Am J Perinatol. 1987;4(3):262\u2013265."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/21\/2\/article-p133.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/21\/2\/133\/1786640\/1551-6776-21_2_133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/21\/2\/article-p133.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/21\/2\/article-p133.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:40:25Z","timestamp":1747356025000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/21\/2\/article-p133.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":20,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-21.2.133","relation":{},"ISSN":["1551-6776"],"issn-type":[{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2016]]}}}